IDL Biotech AB (XSAT:IDL) Days Sales Outstanding : 40.71 (As of Jun. 2021)

View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB Days Sales Outstanding?

IDL Biotech AB's average Accounts Receivable for the three months ended in Jun. 2021 was kr2.82 Mil. IDL Biotech AB's Revenue for the three months ended in Jun. 2021 was kr6.33 Mil. Hence, IDL Biotech AB's Days Sales Outstanding for the three months ended in Jun. 2021 was 40.71.

The historical rank and industry rank for IDL Biotech AB's Days Sales Outstanding or its related term are showing as below:

XSAT:IDL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.94 Med: 69.91 Max: 118.18
Current: 64.9

During the past 13 years, IDL Biotech AB's highest Days Sales Outstanding was 118.18. The lowest was 41.94. And the median was 69.91.

XSAT:IDL's Days Sales Outstanding is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 69.345 vs XSAT:IDL: 64.90

IDL Biotech AB's Days Sales Outstanding declined from Jun. 2020 (99.84) to Jun. 2021 (40.71).

IDL Biotech AB Days Sales Outstanding Historical Data

The historical data trend for IDL Biotech AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB Days Sales Outstanding Chart

IDL Biotech AB Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Days Sales Outstanding

Get a 7-Day Free Trial

70.40

68.37

81.41

102.36

118.18

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Days Sales Outstanding	Get a 7-Day Free Trial															99.84	110.56	60.81	77.26	40.71

Competitive Comparison of IDL Biotech AB's Days Sales Outstanding

For the Diagnostics & Research subindustry, IDL Biotech AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDL Biotech AB's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's Days Sales Outstanding falls into.

IDL Biotech AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

IDL Biotech AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as

	Days Sales Outstanding (A: Dec. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2019 )	+	Accounts Receivable (A: Dec. 2020 ))	/	count )	/	Revenue (A: Dec. 2020 )	*	Days in Period
=	( (9.624	+	4.459)	/	2 )	/	21.748	*	365
=	7.0415					/	21.748	*	365
=	118.18

IDL Biotech AB's Days Sales Outstanding for the quarter that ended in Jun. 2021 is calculated as:

	Days Sales Outstanding (Q: Jun. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2021 )	+	Accounts Receivable (A: Jun. 2021 ))	/	count )	/	Revenue (A: Jun. 2021 )	*	Days in Period
=	( (3.513	+	2.133)	/	2 )	/	6.328	*	365 / 4
=	2.823					/	6.328	*	365 / 4
=	40.71

IDL Biotech AB (XSAT:IDL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

IDL Biotech AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Karlsbodavagen 39, Stockholm, SWE

Website

http://www.idl.se

IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines